TY - JOUR
T1 - Predictors of repeat epinephrine administration for emergency department patients with anaphylaxis
AU - Campbell, Ronna L.
AU - Bashore, Curtis J.
AU - Lee, Sangil
AU - Bellamkonda, Venkatesh R.
AU - Li, James T.C.
AU - Hagan, John B.
AU - Lohse, Christine M.
AU - Bellolio, M. Fernanda
N1 - Funding Information:
Conflicts of interest: R. L. Campbell received consulting fees from the American College of Allergy, Asthma and Immunology. S. Lee has received travel support from Food Allergy Research and Education; and has received research support from the Mayo Foundation. J. T. Hagan has received research support from the National Heart Lung and Blood Institute (NHLBI) (R01 HL 110539), National Institute of Allergy and Infectious Diseases (NIAID) (R01 AI 71106), NHLBI (R01 HL 117823), NIAID (R01 AI 71106), and NHLBI (R01 HL 117823), GlaxoSmithKline (Protocol Number: MEA115661); Astra Zeneca (SOW #3/Study Code D5134C00001); Mayo Clinic; MedImmune, Inc. (MedImmune Protocol No. MEDI9929-1146); AstraZeneca; and Small Grants Program. The rest of the authors declare that they have no relevant conflicts.
Publisher Copyright:
© 2015 American Academy of Allergy, Asthma & Immunology.
PY - 2015
Y1 - 2015
N2 - BACKGROUND: Risk factors that predict which patients with anaphylaxis might require repeat doses of epinephrine are poorly understood. OBJECTIVE: The objective of this study was to identify risk factors associated with the need for multiple doses of epinephrine during an anaphylactic reaction. METHODS: Patients were included if they met diagnostic criteria for anaphylaxis on presentation to the emergency department (ED) at our academic medical center between April 2008 and February 2014. Data were collected on allergic history, presenting signs and symptoms, anaphylaxis management, and disposition. Univariable and multivariable analyses were performed to estimate associations between possible risk factors and the need for multiple doses. RESULTS: Of 582 ED patients with anaphylaxis, 45 (8%) required multiple doses of epinephrine. By multivariable analysis, factors associated with the need for repeat doses were a history of anaphylaxis (odds ratio [OR], 2.5 [95% CI, 1.3-4.7]; P =.005), the presence of flushing or diaphoresis (OR, 2.4 [95% CI, 1.3-4.5]; P =.007), and the presence of dyspnea (OR, 2.2 [95% CI, 1.0-5.0]; P =.046). Patients who received more than 1 dose were more likely to be admitted to the general medical floor (OR, 2.8 [95% CI, 1.1-7.2]; P =.03) or intensive care unit (OR, 7.6 [95% CI, 3.7-15.6]; P <.001). CONCLUSION: Patients with a history of anaphylaxis, flushing or diaphoresis, or dyspnea may require multiple doses of epinephrine to treat anaphylactic reactions. Patients who require more than 1 dose are more likely to be admitted to the hospital, thus increasing health care resource utilization.
AB - BACKGROUND: Risk factors that predict which patients with anaphylaxis might require repeat doses of epinephrine are poorly understood. OBJECTIVE: The objective of this study was to identify risk factors associated with the need for multiple doses of epinephrine during an anaphylactic reaction. METHODS: Patients were included if they met diagnostic criteria for anaphylaxis on presentation to the emergency department (ED) at our academic medical center between April 2008 and February 2014. Data were collected on allergic history, presenting signs and symptoms, anaphylaxis management, and disposition. Univariable and multivariable analyses were performed to estimate associations between possible risk factors and the need for multiple doses. RESULTS: Of 582 ED patients with anaphylaxis, 45 (8%) required multiple doses of epinephrine. By multivariable analysis, factors associated with the need for repeat doses were a history of anaphylaxis (odds ratio [OR], 2.5 [95% CI, 1.3-4.7]; P =.005), the presence of flushing or diaphoresis (OR, 2.4 [95% CI, 1.3-4.5]; P =.007), and the presence of dyspnea (OR, 2.2 [95% CI, 1.0-5.0]; P =.046). Patients who received more than 1 dose were more likely to be admitted to the general medical floor (OR, 2.8 [95% CI, 1.1-7.2]; P =.03) or intensive care unit (OR, 7.6 [95% CI, 3.7-15.6]; P <.001). CONCLUSION: Patients with a history of anaphylaxis, flushing or diaphoresis, or dyspnea may require multiple doses of epinephrine to treat anaphylactic reactions. Patients who require more than 1 dose are more likely to be admitted to the hospital, thus increasing health care resource utilization.
KW - Allergy criteria
KW - Anaphylaxis
KW - Emergency department
KW - Epinephrine
KW - Hypersensitivity
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=84943176023&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84943176023&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2015.04.009
DO - 10.1016/j.jaip.2015.04.009
M3 - Article
C2 - 26032476
AN - SCOPUS:84943176023
SN - 2213-2198
VL - 3
SP - 576
EP - 584
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 4
ER -